Advertisement

Topics

Allergan: $25 Billion Reasons Investors Are Mad

12:14 EST 8 Nov 2017 | Topix

Throughout the last year I have made 2 important calls on Allergan . First I raised concerns about Restasis revenues going away faster than expected as well as concerns about the excessive share repurchases while the valuation was rich I rated the stock a hold then.

Original Article: Allergan: $25 Billion Reasons Investors Are Mad

NEXT ARTICLE

More From BioPortfolio on "Allergan: $25 Billion Reasons Investors Are Mad"

Advertisement
Quick Search
Advertisement
Advertisement